This article showcases our top picks for the best United Arab Emirates based mHealth (Mobile Health) companies. These startups and companies are taking a variety of approaches to innovating the mHealth (Mobile Health) industry, but are all exceptional companies well worth a follow.
We tried to pick companies across the size spectrum from cutting edge startups to established brands.
We selected these startups and companies for exceptional performance in one of these categories:
- Innovative ideas
- Innovative route to market
- Innovative product
- Exceptional growth
- Exceptional growth strategy
- Societal impact
Top United Arab Emirates mHealth (Mobile Health) Companies
Okadoc is a healthtech start-up with a mission to create a better healthcare experience for all. It is the region’s first instant online appointment booking platform that seamlessly connects healthcare providers and doctors with their patients.
Patients can use Okadoc.com to find doctors across 130+ specialities who accept their insurance, instantly book appointments online, receive reminders, reschedule, cancel or even request earlier availability. Okadoc provides both a 24/7 intelligent medical calendar system and a fully interoperable cloud based solution that integrates with most hospital and clinic management systems.
It helps practitioners, clinics and hospitals reduce ‘no-shows’, optimise their bookings, attract and engage new patients. Okadoc’s online marketplace delivers the efficient, seamless, and simple healthcare experience for anyone, anytime, anywhere.
Okadoc is free for patients and available across www.okadoc.com or the app for iPhone and Android. Okadoc’s telemedicine platform enables virtual consultations and connects patients to doctors and healthcare providers across the country..
D-EYE received FDA clearance and CE mark in late 2015, and recently completed 2nd year ISO 13485, 13485 Canada and 9001 audits in June and July 2017.. .
Mondia brings digital entertainment to any device in any country worldwide. As a leading independent digital entertainment enabler, we create and operate digital entertainment solutions for our partners across the globe, ranging from telecom operators and hardware manufacturers to media companies and broadcasters.
Regarded as a world market leader in the B2B digital entertainment market with live services in over 100 countries worldwide, we today enable more than 350 million euros in revenues for our clients. With the ‘Mondia Entertainment Universe’, we established a fully convergent all-in-one solution at a high level of technological expertise.
This platform enables us to deploy fast and keep our clients ahead of their markets. We offer our partners the service of managing, distributing and billing the entire portfolio of entertainment content (Games, Music, Videos, e-Books, Apps etc.) from a single platform – worldwide and to any device (Smartphones, Tablets, Smart-TVs).
As an end-to-end provider, we cover the entire value chain, from licensing, production and distribution of different media types, to payment, storefront marketing and customer support. We offer our business partners complete outsourcing solutions as well as customised service models.
For example, we developed, deployed and currently run the ‘PlayNow’ store for Sony Mobile. This store offers Games, Music, Apps, e-Books and more.
It is pre-embedded on Sony smartphones in around 75 countries worldwide. The best possible user experience for the consumer and the commercial success of our business partners is always at the forefront of what we do.
KeepVision offers a mobile application to monitor school children’s vision with the help of a smartphone. It measures main visual parameters which include visual acuity and contrast sensitivity.
If any deviations occur, the app recommends the user to visit a relevant eye care professional.. APDM is a full stack engineering team (hardware, software, algorithm) with a strong scientific foundation.
We are unique in digital health because of our scientific roots, ensuring that all commercial products are rigorously studied and validated by third party researchers. APDM’s future revenue growth (historically since commercialization in 2011 +30% YOY) is set to accelerate over the next 10 years related to the expanding demand for objective, digital endpoints in clinical trials, and ultimately reaching the patient as a companion device to pharmaceutical drugs as the drug delivery landscape continues to adopt more at-home efficacy monitoring.
For more information, please visit our website, www.apdm.com. We feel as though the hand and wrist market has been untapped for innovation – and we intend to step outside the box to address unmet needs while still providing strong, rigid fixation that has been proven throughout the years..
Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs. The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations.
Moreover, NCDs leave populations more susceptible to communicable diseases such as coronaviruses, influenza and tuberculosis. During the COVID-19 pandemic of 2020, 78% of people admitted to ICU in the US and 94% of those who died had underlying health conditions (CDC).
NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women.
Only since 1994, when the United States’ National Institutes of Health (NIH) mandated that women and minorities were to be included as subjects in clinical research, has the research community entertained the fact that sex and/or gender differences might affect clinical outcomes. Today, women using drugs that were approved by the early 90s, are 50–75% more likely than men to suffer adverse reactions to those therapies.
Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes.
Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues.
EazeTx© is our innovative online software suite connecting Doctors, Labs, Pharmacies – all players in the treatment chain. The entire medical consultation to medicine dispersal cycle, with assured patient follow-ups, is brought under one roof.
In the current Corona impacted world, EazeTx was also further equipped with tele-consultation facility. This option is attractive to hospitals also.
Video/online consultation NMC healthcare, UAE, has partnered with our client UDENZ, to offer dental first level consultations online. European Medical Centre, a clinic chain in Umm Al Quwain is also offering online consultations using EazeTx to its patients..
Its bots are also used by pharmaceutical companies to improve their patient programs and increase medication adherence. It is also involved in several major clinical research studies.
TNH Health is based in Brazil with offices in São Paulo and Santa Catarina states.. Our customers.
Our customers are physical rehabilitation centres (public and private, outpatient and inpatient) and insurance companies. As a part of scaling, we also consider b2c sales.
MyMedicNow ( Pulse FZ LLC)
MymedicNow ( a product of Pusle FZ LLC) is a free of cost of service for health care seekers,Which will allow them to search for doctors/hospitals/clinicsFrom app (iOS or android) or Computers, make appointments, Store their records, rate the services. It’s a service which will Connect the medical service seeker and the medical service Provider digitally..
It also monitors its users’ natural vitamin D production and recommends when to use sunscreen. Ultra offers Violet Plus, a smart device that sends alerts about UV exposure.
Ultra was founded by Nabyl Bennouri, Nattapon Chaimanonart, and Jie Lian in 2014. It is headquartered in Portland, Oregon..
We are a technology partner of leading software product development companies to provide complete product lifecycle services. Diaspark’s Mobile practice has extensive experience in Enterprise Mobility, Information and Entertainment Applications.
We have worked on multiple smartphone platforms and technologies such as Java, BREW, Windows Mobile, Symbian, Palm OS, Blackberry, i-Phone and Android. For more indepth review, pls.
visit our our website.. .
MedsConnect is a chronic disease management application that enables its users to keep health records.. LawyerUp gets a top-notch, pre-screened lawyer working within 15 minutes.
Guaranteed. Users who sign-up are prepared for that “one call” they hope they never get, or have to make.
Users immediately get important legal protections, advice, and connection to friends and family who can help. LawyerUp is entirely user-supported.
No lawyer pays us to join or get a case.. miCARD is a socially aware company, and our affiliations with select partner organizations are designed to help individuals improve their personal health outcomes while benefiting others through cause awareness and charitable funding.
We seek your participation in this effort and welcome any suggestions for alignment in partnership or charitable relations.. .
MMG MENA is the Middle East-Northern Africa subsidary of MMG (former MedLab Media Group). The end-user will be able to share the records with any trusted person including healthcare providers, family and friends.
We also provide a dashboard for physicians where they can follow the patients wherever they go and be able to have a 360 degree view of the patient. Our primary focus is on enabling doctors to reduce the cost on medicare patients thus increasing their rewards from CMS.
Our app will have the ability to integrate with personal digital assistants like Alexa for medication reminders, annual mammograms, etc In the future, we would like to provide patients with the “Facebook of Medicine” where there is a safe space for sharing medical conditions anonymously. Once we reach a critical threshold we should be able to employ data analytics to provide basis for personalized medicine.
DocJournal allows sharing of feedback and information between users and providers, to help drive improved care.. .
– PREDICTIX Genetics – 47% improvement in prescribing accuracy*. Further optimizes treatment decisions by combining a patient’s DNA analysis with AI.
PREDICTIX is an ideal software solution for payors, providers, DNA laboratories and telemedicine providers to improve patient outcomes, reduce costs and expand service offerings in the mental health space. PREDICTIX is commercially available in Europe.
You may write to us at: Leap Droid/Fupping Ltd, 349 Royal College Street, London, England, NW1 9QS.